2019
DOI: 10.1002/jnr.24441
|View full text |Cite
|
Sign up to set email alerts
|

The impact of postsynaptic density 95 blocking peptide (Tat‐NR2B9c) and an iNOS inhibitor (1400W) on proteomic profile of the hippocampus in C57BL/6J mouse model of kainate‐induced epileptogenesis

Abstract: Antiepileptogenic agents that prevent the development of epilepsy following a brain insult remain the holy grail of epilepsy therapeutics. We have employed a label-free proteomic approach that allows quantification of large numbers of brain-expressed proteins in a single analysis in the mouse (male C57BL/6J) kainate (KA) model of epileptogenesis. In addition, we have incorporated two putative antiepileptogenic drugs, postsynaptic density protein-95 blocking peptide (PSD95BP or Tat-NR2B9c) and a highly selectiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 76 publications
(106 reference statements)
0
7
0
Order By: Relevance
“…In addition, a recent study demonstrated that pharmacological inhibition of Fyn decreased Fyn and tau interaction in a mouse model of tauopathy and prevented neurodegeneration resulting in improved learning and memory (Tang et al, 2020 ). Other approaches, such as inducing site-specific tau phosphorylation at Thr205 or blocking PSD-95 using tat-NR2B9c peptide have been reported to dissociate NR2B/PSD-95/tau/Fyn complexes leading to the rescue of neurotoxicity (Ittner et al, 2016 ; Tse et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, a recent study demonstrated that pharmacological inhibition of Fyn decreased Fyn and tau interaction in a mouse model of tauopathy and prevented neurodegeneration resulting in improved learning and memory (Tang et al, 2020 ). Other approaches, such as inducing site-specific tau phosphorylation at Thr205 or blocking PSD-95 using tat-NR2B9c peptide have been reported to dissociate NR2B/PSD-95/tau/Fyn complexes leading to the rescue of neurotoxicity (Ittner et al, 2016 ; Tse et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…The hippocampal lysates were processed for proteome analysis, as described previously ( 33 ). For digestion, 15 μl (~100 μg) of homogenate was diluted to 160 μl of ammonium bicarbonate in LoBind tubes.…”
Section: Methodsmentioning
confidence: 99%
“…All peptide separations were carried out using a nanoAcquity UPLC™ system (Waters MS Technologies, Manchester, UK), as previously described ( 33 ). For each analysis, 1 μl of sample digest was loaded onto a trapping column (C 18 , 180 μm × 20 mm, Waters), using partial loop injections for 3 min at 5 μl/min with an aqueous solution containing 0.1% (v/v) TFA and 2% (v/v) acetonitrile.…”
Section: Methodsmentioning
confidence: 99%
“…With the kainic acid-induced status epilepticus, 1400 W, by decreasing the epileptiform spike rate in the first three days of after status epilepticus and can potentially modify the development of epileptogenesis and reduce the severity of chronic epilepsy [ 134 ]. Thus, 1400W is also revealed to modulate proteins involving neuroinflammatory responses such as heat shock protein beta-1, glial fibrillary acidic protein, and CD44 antigen in kainic acid-induced status epilepticus [ 178 ]. No clinical trial was found regarding “brain disease and 1400 W” from ClinicalTrials.gov.…”
Section: The Potentials Of Antioxidants In Status Epilepticusmentioning
confidence: 99%